Internal Medicine · Brooklyn, NY
NPI
1235239799
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
474 Ovington Ave Ste Ll
Brooklyn, NY, 11209
Phone (718) 238-2625
Groups this clinician bills Medicare through
Medicare paid, 2024
$97K
2,914 services
Medicare patients, 2024
169
Average age 73
Drug cost, 2024
$531K
3,735 prescriptions
Company payments, 2025
$2,506
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Fred E Notarnicola Sr. was code 99213 (office e&m - established), 292 times for 122 patients. In total Fred E Notarnicola Sr. billed 2,914 services in 76 codes, and Medicare paid $97K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 292 | 122 | $77.79 | $23K |
| 99214 Office E&M - Established | Office | 189 | 113 | $101.15 | $19K |
| 99441 Telephone Services | Office | 181 | 91 | $41.45 | $7,502 |
| 36415 Venipuncture Blood Collection | Office | 123 | 92 | $8.65 | $1,064 |
| 93000 Electrocardiogram | Office | 103 | 81 | $12.04 | $1,241 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 85 | 43 | $35.95 | $3,056 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 85 | 43 | $45.42 | $3,861 |
| 80048 Clinical Chemistry | Office | 64 | 60 | $8.29 | $531 |
| 84443 Clinical Chemistry | Office | 64 | 60 | $16.46 | $1,053 |
| 83525 Clinical Chemistry | Office | 64 | 60 | $11.20 | $717 |
| 82550 Clinical Chemistry | Office | 64 | 60 | $6.38 | $408 |
| 83735 Clinical Chemistry | Office | 64 | 60 | $6.57 | $420 |
| 84100 Clinical Chemistry | Office | 64 | 60 | $4.65 | $298 |
| 80076 Clinical Chemistry | Office | 64 | 60 | $8.01 | $513 |
| 82150 Clinical Chemistry | Office | 64 | 60 | $6.35 | $406 |
By year: 2022 $160K for 6,763 services; 2023 $172K for 7,465 services; 2024 $97K for 2,914 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 123 | 92 | $8.65 | $1,064 |
| 84100 Clinical Chemistry | 64 | 60 | $4.65 | $298 |
| 80076 Clinical Chemistry | 64 | 60 | $8.01 | $513 |
| 82150 Clinical Chemistry | 64 | 60 | $6.35 | $406 |
| 83735 Clinical Chemistry | 64 | 60 | $6.57 | $420 |
| 83615 Clinical Chemistry | 64 | 60 | $5.92 | $379 |
| 82530 Clinical Chemistry | 64 | 60 | $16.38 | $1,048 |
| 82550 Clinical Chemistry | 64 | 60 | $6.38 | $408 |
| 83525 Clinical Chemistry | 64 | 60 | $11.20 | $717 |
| 80048 Clinical Chemistry | 64 | 60 | $8.29 | $531 |
Medicare prescription drug claims, 2024
In 2024, the drug Fred E Notarnicola Sr. prescribed most often to Medicare patients was Ozempic (Semaglutide), with 135 prescriptions and refills. In total Fred E Notarnicola Sr. wrote 3,735 Medicare prescriptions that cost $531K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 135 | 165 | 21 | $150K |
| Azithromycin Generic | 126 | 126 | 74 | $351 |
| Levothyroxine Sodium Generic | 117 | 246 | 26 | $1,340 |
| Rosuvastatin Calcium Generic | 114 | 261 | 31 | $678 |
| Losartan Potassium Generic | 114 | 324 | 36 | $1,412 |
| Methylprednisolone Generic | 109 | 109 | 61 | $600 |
| Pantoprazole Sodium Generic | 85 | 187 | 28 | $555 |
| Atorvastatin Calcium Generic | 83 | 175 | 26 | $673 |
| Prednisone Generic | 78 | 86 | 37 | $215 |
| Omeprazole Generic | 77 | 165 | 19 | $581 |
| Metformin Hcl Generic | 72 | 168 | 20 | $469 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 68 | 85 | 24 | $2,579 |
| Furosemide Generic | 62 | 120 | 16 | $232 |
| Metoprolol Succinate Generic | 61 | 135 | 19 | $671 |
| Gabapentin Generic | 57 | 84 | 15 | $754 |
Brand drugs: 646 claims; generic drugs: 3,063 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Fred E Notarnicola Sr. $2,506 ($2,506 in general payments such as food, travel and fees) from 20 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $620.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 9 | $620 |
| Axsome Therapeutics, Inc. AXSM | 3 | $345 |
| Abbvie Inc. ABBV | 3 | $311 |
| Neurelis, Inc. | 1 | $150 |
| Pfizer Inc. PFE | 8 | $148 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $125 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 1 | $125 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $112 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $111 |
| Lilly USA, LLC LLY | 7 | $107 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.